NASDAQ:PLXSPlexus Stock Price, Forecast & News

Plexus' stock was trading at $60.68 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, PLXS stock has increased by 13.3% and is now trading at $68.74. View which stocks have been most impacted by Coronavirus.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Plexus in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Plexus.

Plexus is scheduled to release its next quarterly earnings announcement on Wednesday, July 22nd 2020. View our earnings forecast for Plexus.

Plexus will be holding an earnings conference call on Wednesday, July 22nd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Plexus Corp. (NASDAQ:PLXS) issued its quarterly earnings data on Wednesday, April, 22nd. The technology company reported $0.61 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.56 by $0.05. The technology company earned $767 million during the quarter, compared to analyst estimates of $741.22 million. Plexus had a net margin of 3.27% and a return on equity of 11.45%. Plexus's quarterly revenue was down 2.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.79 EPS. View Plexus' earnings history.

Plexus issued an update on its third quarter earnings guidance on Wednesday, April, 22nd. The company provided earnings per share (EPS) guidance of $0.72-0.82 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.67. The company issued revenue guidance of $790-830 million, compared to the consensus revenue estimate of $763.23 million.

5 Wall Street analysts have issued twelve-month target prices for Plexus' shares. Their forecasts range from $67.00 to $83.00. On average, they expect Plexus' share price to reach $75.00 in the next twelve months. This suggests a possible upside of 9.1% from the stock's current price. View analysts' price targets for Plexus.

Media coverage about PLXS stock has been trending very negative recently, InfoTrie reports. The research group identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Plexus earned a media sentiment score of -3.6 on InfoTrie's scale. They also assigned media coverage about the technology company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news about Plexus.

Plexus saw a decrease in short interest during the month of June. As of June 30th, there was short interest totaling 754,200 shares, a decrease of 32.1% from the June 15th total of 1,110,000 shares. Based on an average trading volume of 192,500 shares, the short-interest ratio is currently 3.9 days. Currently, 2.7% of the company's shares are short sold. View Plexus' Current Options Chain.

Some companies that are related to Plexus include Trimble (TRMB), IPG Photonics (IPGP), Jabil (JBL), Mercury Systems (MRCY), Fabrinet (FN), Sanmina (SANM), KEMET (KEM), TTM Technologies (TTMI), Methode Electronics (MEI), Benchmark Electronics (BHE), CTS (CTS), Park Electrochemical (PKE), Neonode (NEON) and Key Tronic (KTCC). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Plexus investors own include Bristol-Myers Squibb (BMY), Walgreens Boots Alliance (WBA), Berry Global Group (BERY), Cisco Systems (CSCO), Gilead Sciences (GILD), Intel (INTC), Pfizer (PFE), QUALCOMM (QCOM), Twitter (TWTR) and ConocoPhillips (COP).

Plexus trades on the NASDAQ under the ticker symbol "PLXS."

Plexus' stock is owned by many different institutional and retail investors. Top institutional shareholders include State of Alaska Department of Revenue (0.09%), Envestnet Asset Management Inc. (0.09%), Diversified Trust Co (0.02%) and Cypress Capital Group (0.01%). Company insiders that own Plexus stock include Angelo Michael Ninivaggi Jr, David J Drury, Dean A Foate, Michael V Schrock, Patrick John Jermain, Peter Kelly, Ralf R Boer, Ronnie Darroch, Scott Theune, Stephen P Cortinovis, Steven J Frisch, Todd P Kelsey and Yong Jin Lim. View institutional ownership trends for Plexus.

PLXS stock was acquired by a variety of institutional investors in the last quarter, including Diversified Trust Co, Cypress Capital Group, Envestnet Asset Management Inc., and State of Alaska Department of Revenue. View insider buying and selling activity for Plexus.

Shares of PLXS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PLXS stock can currently be purchased for approximately $68.74.

Plexus has a market capitalization of $2.01 billion and generates $3.16 billion in revenue each year. The technology company earns $108.62 million in net income (profit) each year or $3.43 on an earnings per share basis. Plexus employs 19,000 workers across the globe.

The official website for Plexus is www.plexus.com.

Plexus' mailing address is One Plexus Way, Neenah WI, 54957. The technology company can be reached via phone at 920-969-6000 or via email at [email protected]